A phase I study of trastuzumab-DM1 (T-DM1), a first-in-class HER2 antibody-drug conjugate (ADC), in patients (pts) with advanced HER2+ breast cancer (BC)
| Publication | Article in Journal of Clinical Oncology, published May 2008 |
|---|---|
| Authors | M. Beeram, H. A. Burris, S. Modi, M. Birkner, S. Girish, J. Tibbitts, S. N. Holden, S. G. Lutzker...[ show more ] |
This is the public page for a publication record in Dimensions, a free research insights platform that brings together information about funding, scholarly outputs, policy, patents and grants.
Loading metrics…